This website uses cookies to improve your experience. Learn more about cookies and how to manage them.



Society shares findings from 2021 member survey

29 Jul 2021

The Society shares the important findings from our 2021 member survey.  

Society welcomes publication of new report on equity in the STEM workforce

20 Jul 2021

The Society welcomes publication of the report and recommendations arising from the All Party Parliamentary Group (APPG) on Diversity and Inclusion in STEM inquiry on ‘Equity in the STEM workforce’.

Society welcomes the government’s new life sciences vision

07 Jul 2021

The UK government has today published its ten-year strategy for the life sciences. Building on the successes of the COVID-19 response, the strategy aims to help the NHS to solve the UK’s biggest health challenges by creating an “environment in which industry can grow and succeed in the UK, and patients and the NHS can receive a real benefit”.

Society Honorary Fellow Sir Patrick Vallance appointed National Technology Adviser

21 Jun 2021

The UK Government’s Chief Scientific Advisor and Honorary Fellow of the British Pharmacological Society, Sir Patrick Vallance, has been appointed National Technology Advisor for the new Office for Science & Technology Strategy.  

Society calls for contributions from LGBTQ+ pharmacologists

18 Jun 2021

The Society is inviting contributions from LGBTQ+ pharmacologists for a themed issue of Pharmacology Matters. 

Members recognised in 2021 Queen’s Birthday Honours

16 Jun 2021

Several members of the Society have been recognised for their achievements in the 2021 Queen's Birthday Honours.

Society welcomes COVID-19 vaccine approval (updated 4 June 2021)

04 Jun 2021

On 2 December 2020, the government announced that it accepted the Medicines Healthcare products Regulatory Agency (MHRA) recommendation to approve Pfizer-BioNTech’s COVID-19 vaccine. The approval is the first in the world, for a vaccine that has undergone large-scale clinical trials. Update: On 4 June 2021 the MHRA approved an extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its use in 12- to 15-year-olds.  

Society welcomes new CQC strategy focus on research

27 May 2021

The independent regulator of health and social care in England, the Care Quality Commission (CQC), has today published its new strategy, recognising the benefits of clinical research to patient outcomes.

Society opens applications for new Inclusive Pharmacology Education Steering Group

13 Apr 2021

Following the launch of our Vision for equality, diversity and inclusion, we will be supporting inclusive pharmacology education as a priority for 2021. We have set up an inclusive pharmacology steering group to guide these activities. Find out how to apply.

MHRA issues new advice regarding Oxford-AstraZeneca COVID-19 vaccine

07 Apr 2021

Society President Professor Sir Munir Pirmohamed spoke today at a press conference about the Oxford-Astra Zeneca COVID-19 vaccine, and outlined the new advice.